Singer Capital Markets
Chris Glasper is a seasoned Healthcare Equity Research Analyst at Singer Capital Markets, a position held since October 2012, where involvement includes covering approximately 15 UK listed companies and contributing to the IPOs of CareTech and Synexus. Prior experience encompasses roles as Partner in Equity Research at N+1 Brewin and Director of Equity Research at Brewin Dolphin, where Chris also started as an Analyst. An academic background includes a BA Hons in Economics & Politics from the University of York and education at the Royal Grammar School Newcastle.
This person is not in any teams
Singer Capital Markets
Singer Capital Markets is a leading Investment Bank dedicated to supporting ambitious UK growth companies and their investors. We have specialist capabilities, deep experience, and a proven track record of client success in the UK small & mid cap market. Our business is built on over 100 years of capital markets heritage and is today one of the largest corporate stockbroking platforms in the City. We offer a fully integrated service which provides our clients with: 1) Advice – A trusted partner and market advocate to UK PLC's (Corporate Broking, Equity Capital Markets and M&A) 2) Capital – Proven fundraising firepower (IPO’s, Follow on Offerings and Private Capital) 3) Liquidity – Driving activity in our clients’ shares (Sales Trading and Market Making) Whatever your growth ambitions, our team of market-leading experts are well equipped to help you succeed on your corporate journey.